about
DNA methylation and microRNA dysregulation in cancerMicroRNAs as potential signatures of environmental exposure or effect: a systematic reviewHuman papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review).MicroRNA: important player in the pathobiology of multiple myelomaEpigenetic targeting of ovarian cancer stem cellsRNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma.Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic cryptGenome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders.Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication.Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.DNA methylation of microRNA genes in multiple myeloma.Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.Aberrant microRNA expression in multiple myeloma.Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.The role of epigenetics in the biology of multiple myeloma.DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.Understanding the CREB1-miRNA feedback loop in human malignancies.Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.Epigenetic regulation of microRNA expression in Hodgkin lymphoma.RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myelomaDownregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.Methylation and microRNA-mediated epigenetic regulation of SOCS3.Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.Epigenetic silencing of LPP/miR-28 in multiple myeloma.
P2860
Q26998741-6A8E2780-037D-44C5-A82E-CBA83CFA17A2Q28393390-2269C0B8-BB3D-4429-BE60-0CE759217AECQ33747273-0B978B32-6EC5-4544-BB93-90E28B17FE2AQ33786861-967275B5-F03B-444D-B564-53EEFD35A8BCQ34135466-F29C0600-7645-456F-B2CF-C790A2DB0297Q34974049-F40A4C46-94C2-4C54-AD48-41FDE977B50CQ35768988-23584A87-C6C9-45A2-BE56-1F5E02E961B6Q36094729-2BFC3142-9530-4FAC-8418-107D87631DF7Q36359569-6669A447-73B6-4EB7-BA1F-E85D4883DD4FQ36413501-D3A0C8B2-87EE-4C79-A8BF-0F2D1EA12D6EQ36422143-443FB46E-7DB5-47BA-8A7E-572F0B37ABCEQ36688994-CF2BC58E-144C-4B15-8424-B8C884EC8229Q36862536-64F0C2AB-C040-449D-B0C5-1B7A113C2A2BQ37424922-0D1E17FC-C652-44AE-951F-0FAD67B078EAQ37616347-F5649776-B05B-4B8B-BDAB-85887F5F27ECQ38020153-9C5A810D-3F7C-443B-94B8-340F3536DAD3Q38059899-9A04F2BC-9F38-420A-8156-426EE602DD93Q38099048-C63F38E7-9ABF-4D63-8A8C-6708D0E3FE96Q38108387-3E018A0A-9F1A-40FE-BEF7-2E874982FB50Q38208520-CB0D8BBB-F62E-4808-8CCF-34FB48C7B5A7Q38343779-86696A98-AC34-442A-BFEB-0B578EDEC847Q38595057-F030C609-3C80-4608-9AE8-5B6FC884F4B3Q38664137-5E00DE98-513E-4634-9820-376FEBEC8A97Q38802458-38AAC899-59E9-496F-A107-799E6E89AD32Q38885469-58F141DC-D9FB-4418-8F5D-921596CCC3CFQ38889464-73A97736-A6B9-47ED-9F95-0929548F02D6Q38920243-25443E25-70EE-49E2-BD35-66CDB0AEA49DQ38967891-89F5413A-A975-4BE5-A4FF-4132B5129AA3Q39515650-CE10A395-0E67-4F91-A8A6-F6FAE162166FQ41240274-0A0BB2DB-A154-497D-8A13-DAF335CC3DECQ46830544-05BE0248-1FED-4282-95B7-A393D697F1EDQ53027590-FEA3A59E-BEE6-4C9C-93F6-ECC944699FF8Q55263293-29640BE6-4580-4626-AC08-6CA3E8745D09
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Epigenetic silencing of MIR203 in multiple myeloma.
@en
Epigenetic silencing of MIR203 in multiple myeloma.
@nl
type
label
Epigenetic silencing of MIR203 in multiple myeloma.
@en
Epigenetic silencing of MIR203 in multiple myeloma.
@nl
prefLabel
Epigenetic silencing of MIR203 in multiple myeloma.
@en
Epigenetic silencing of MIR203 in multiple myeloma.
@nl
P2093
P2860
P1476
Epigenetic silencing of MIR203 in multiple myeloma
@en
P2093
Chi-Chiu So
Dong-Yan Jin
Joseph F Costello
Raymond Liang
P2860
P304
P356
10.1111/J.1365-2141.2011.08782.X
P407
P577
2011-06-28T00:00:00Z